SEC-sourced researchBeta

LAB

STANDARD BIOTOOLS INC.

US markets

Data passport

CIK: 0001162194
Exchange: Nasdaq
Business activity: — · SIC 3826
Financial inputs: 6/6
Filing date: Oct 5, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

LAB · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2023	106,340,000.0000	Mar 16, 2026
December 2024	91,008,000.0000	Mar 16, 2026
December 2025	85,331,000.0000	Mar 16, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	85,331,000.0000	-74,896,000.0000	-74,343,000.0000	567,754,000.0000	143,463,000.0000	Mar 16, 2026
December 2024	91,008,000.0000	-138,885,000.0000	-143,454,000.0000	612,345,000.0000	140,623,000.0000	Mar 16, 2026
December 2023	106,340,000.0000	-74,656,000.0000	-43,287,000.0000	—	—	Mar 16, 2026

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenueFromContractWithCustomerExcludingAssessedTax	$85.33M	December 2025	Mar 16, 2026	10-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax	$91.01M	December 2024	Mar 16, 2026	10-K
Net incomeNetIncomeLoss	-$74.9M	December 2025	Mar 16, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$74.34M	December 2025	Mar 16, 2026	10-K
Total assetsAssets	$567.75M	December 2025	Mar 16, 2026	10-K
Total liabilitiesLiabilities	$143.46M	December 2025	Mar 16, 2026	10-K

New filings

Explore methodology ↗